U.S. Water Utilities Stock News

NYSE:NEE
NYSE:NEEElectric Utilities

NextEra’s US$2 Billion Hybrid Equity Units Offering Might Change The Case For Investing In NEE

NextEra Energy, Inc. recently completed a US$2.00 billion public offering of 40,000,000 equity units at US$50.00 each, with a US$0.75 per unit discount, combining future stock purchase contracts with debentures issued by NextEra Energy Capital Holdings and guaranteed by the parent company. The company plans to channel the proceeds into funding energy and power projects, general corporate purposes, and repayment of outstanding commercial paper, underscoring how it is using hybrid equity–debt...
NYSE:PB
NYSE:PBBanks

Prosperity Bancshares Attracts Takeover Interest With Texas Scale And Valuation Gap

Prosperity Bancshares (NYSE:PB) is reportedly attracting acquisition interest tied to its Texas focused franchise. Recent changes to executive change in control agreements suggest management could be more aligned with a potential sale. Takeover speculation is emerging as regional bank M&A activity remains active across the sector. Prosperity Bancshares, trading at $70.04, sits at the center of fresh takeover chatter as larger banks and peers look for scale in Texas. The company is drawing...
NYSE:NCLH
NYSE:NCLHHospitality

Assessing Norwegian Cruise Line Holdings (NCLH) Valuation After Recent Share Price Volatility

Why Norwegian Cruise Line Holdings (NCLH) is on investors’ radar Norwegian Cruise Line Holdings (NCLH) has drawn attention after recent share price swings, with a 1-day return near a 4% decline and a past week move around an 11% decline shaping sentiment. Over the past month the stock shows roughly a 3% decline, while the past 3 months reflect about a 13% total return, giving investors a mixed short-term picture to weigh against longer-term performance and fundamentals. See our latest...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

A Look At C.H. Robinson Worldwide’s Valuation After Mixed Q4 2025 Results And Cost Cuts

C.H. Robinson Worldwide (CHRW) is back in focus after mixed fourth quarter 2025 results, with earnings above expectations, revenue weaker, and management highlighting cost cuts, capital spending plans, and continued cash returns to shareholders. See our latest analysis for C.H. Robinson Worldwide. The recent fourth quarter update and upcoming conference appearance come after a 21.17% 90 day share price return and a 100.88% 1 year total shareholder return, suggesting momentum has picked up...
NYSE:CHH
NYSE:CHHHospitality

Dividend Debut and Leadership Change Could Be A Game Changer For Choice Hotels International (CHH)

Choice Hotels International recently reported its fourth-quarter and full-year 2025 results, highlighted by higher annual net income of US$369.95 million and diluted EPS of US$7.90, alongside a new quarterly cash dividend of US$0.2875 per share payable on April 15, 2026 to shareholders of record on April 1, 2026. These updates, released around the same time as long-serving Senior Vice President and General Counsel Simone Wu announced plans to retire in 2026, combine solid profitability,...
NYSE:ANF
NYSE:ANFSpecialty Retail

A Look At Abercrombie & Fitch’s Valuation As Q4 Earnings Draw Investor Attention

Abercrombie & Fitch (ANF) is back on investor radars as it prepares to report Q4 earnings, following recent quarters of revenue growth, maintained guidance, and steady analyst estimates that highlight interest in the stock. See our latest analysis for Abercrombie & Fitch. The recent 7 day share price return of 4.45% and 1 day gain of 1.40% to US$99.22 sit against a softer year to date share price return of 19.82% and a very strong three year total shareholder return of about 2.5x. Together,...
NasdaqCM:DNTH
NasdaqCM:DNTHBiotechs

Assessing Dianthus Therapeutics (DNTH) Valuation After A Strong Year Of Share Price Gains

Event-driven snapshot of Dianthus Therapeutics Dianthus Therapeutics (DNTH) has drawn investor attention after recent trading moves, with the stock closing at US$55.39 as the company advances clinical-stage complement therapeutics for severe autoimmune and inflammatory diseases. See our latest analysis for Dianthus Therapeutics. Recent trading fits into a strong run for the stock, with a 90 day share price return of 25.97% and year to date share price return of 39.59%, while the 1 year...
NYSE:BORR
NYSE:BORREnergy Services

Assessing Borr Drilling (BORR) After A Volatile Year Of Share Price Swings

If you are wondering whether Borr Drilling's share price reflects its true value, this article will walk through the key numbers that matter before you make up your mind. The stock has been volatile recently, with a 4.6% decline over the last 7 days, a 23.9% gain over 30 days, and returns of 45.4% year to date and 147.9% over the past year. This compares to a 16.8% decline over 3 years and a 160.9% gain over 5 years. These swings have drawn renewed attention to Borr Drilling, as investors...
NYSE:BHC
NYSE:BHCPharmaceuticals

Xifaxan Win And Bausch Plus Lomb Spinoff Plans Reframe Bausch Health

Bausch Health Companies (NYSE:BHC) reported a major legal win that secures patent protection for its gastrointestinal drug Xifaxan. The outcome reduces the risk of near term generic competition for Xifaxan, a key product in the company’s portfolio. Management also confirmed further progress on plans to partially spin off Bausch + Lomb through a separate public listing. Bausch Health Companies, trading at $5.73, has seen pressure on its share price over multiple time frames, with a 20.5%...
NYSE:ST
NYSE:STElectrical

A Look At Sensata Technologies Holding (ST) Valuation After Recent Share Price Pullback

Why Sensata Technologies Holding (ST) is on investors’ radar today Sensata Technologies Holding (ST) has drawn attention after recent share price moves, with the stock closing at US$35.30 and showing mixed performance over the past week, month, and past 3 months. See our latest analysis for Sensata Technologies Holding. That recent 4.2% 1 day share price decline and 8.0% 7 day share price pullback sit against a 30 day share price return of 2.1% and a 1 year total shareholder return of 35.1%...
NYSE:THO
NYSE:THOAuto

Thor Industries Q2 Margin Uptick And EPS Swings Test Bullish Recovery Narrative

Thor Industries (THO) has just posted its Q2 2026 numbers, with recent quarterly revenue running at about US$2.4 billion and basic EPS of US$0.41, while over the last twelve months revenue totaled roughly US$9.8 billion and EPS reached US$5.32. The company has seen quarterly revenue range between US$2.0 billion and US$2.9 billion since early 2024, with basic EPS moving from a loss of US$0.03 in early 2025 to US$2.54 at its recent peak and US$0.41 in the latest quarter. This gives a clearer...
NYSE:WK
NYSE:WKSoftware

Why Workiva (WK) Is Up 8.4% After Swing to Profitability and Higher 2026 Guidance

Workiva Inc. reported past fourth-quarter 2025 results with revenue of US$238.94 million and net income of US$11.82 million, and issued 2026 guidance calling for full-year revenue of about US$1.04 billion and GAAP net income per diluted share of US$0.70 to US$0.80. The shift from a loss a year ago to profitability in the latest quarter, alongside higher revenue and earnings guidance, highlights improving operating leverage and management confidence in the business model. With Workiva pairing...
NYSE:FPS
NYSE:FPSElectrical

Forgent Power Solutions (FPS) Valuation Check After Recent 6.7% Share Price Pullback

Forgent Power Solutions (FPS) has drawn attention after a sharp 6.7% one day share price decline, prompting investors to reassess its earnings profile, revenue base of about US$882.4 million, and current valuation metrics. See our latest analysis for Forgent Power Solutions. The 6.7% one day share price return decline to US$33.57 comes after a relatively resilient year to date, with an approximately 15.8% year to date share price return suggesting momentum has cooled recently rather than...
NYSE:IBM
NYSE:IBMIT

IBM Confluent Deal And Claude Code Put AI Focus In View

IBM (NYSE:IBM) is acquiring Confluent, a data streaming and analytics company, to deepen its AI and cloud computing offerings for enterprise clients. The deal is aimed at reinforcing IBM's role in mission critical workloads across Fortune 500 customers that rely on real time data and hybrid cloud setups. Anthropic has launched Claude Code, a coding assistant that can work with legacy COBOL, a language central to many IBM mainframe environments. Claude Code introduces an external tool that...
NYSE:LADR
NYSE:LADRMortgage REITs

Assessing Ladder Capital (LADR) Valuation After New US$675 Million Liquidity Commitments

Ladder Capital’s new financing moves put liquidity in focus Ladder Capital (LADR) recently lined up $675 million in new unsecured capital commitments, including a larger revolving credit facility and a fresh delayed draw term loan, putting its funding access and flexibility in the spotlight for investors. See our latest analysis for Ladder Capital. Despite the fresh $675 million in unsecured capital commitments, Ladder Capital’s recent trading has been softer, with a 30 day share price return...
NYSE:FOUR
NYSE:FOURDiversified Financial

Shift4 Payments Expands With xAI Partnership And Bambora Acquisition

Shift4 Payments (NYSE:FOUR) has partnered with xAI to integrate AI assistants into its customer service operations. The company is also pushing ahead with international expansion initiatives. Shift4 has completed its acquisition of Bambora North America, adding a large merchant base to its network. The Bambora deal is expected to broaden Shift4's integrated payments platform and create new cross-sell opportunities. Shift4 Payments comes into this news cycle after a difficult share price...
NYSE:SYY
NYSE:SYYConsumer Retailing

How Investors Are Reacting To Sysco (SYY) Raising EPS Guidance On Strong International Momentum

In February 2026, Sysco Corporation reported fiscal second-quarter revenue and earnings growth that exceeded analyst expectations and raised its adjusted earnings per share guidance for fiscal 2026 toward the upper end of its prior range, supported by strong international segment performance and improved operating leverage. This guidance upgrade, alongside Sysco’s expanding role in initiatives such as locally sourced products and nationwide distribution partnerships, highlights management’s...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Coinbase Stock Slips As 24 Hour Commission Free Trading Broadens Its Role

Coinbase Global (NasdaqGS:COIN) has launched commission free, 24 hour trading for U.S. stocks and ETFs. The new service brings traditional securities onto Coinbase’s platform alongside crypto assets. The move marks an expansion of Coinbase’s product set beyond its core crypto trading business. Coinbase Global, trading at $182.36 as of the last close, is extending its reach beyond crypto by adding commission free U.S. stock and ETF trading that runs around the clock. The company’s shares are...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY) Margin Compression And One Off Loss Reinforce Bearish Earnings Narratives

Best Buy FY 2026 results: revenue steady, EPS under pressure as margins stay thin Best Buy (BBY) has reported third quarter FY 2026 results with revenue of US$9.7b and basic EPS of US$0.66, setting the tone for a year where earnings quality is very much in focus. Over the past three quarters of FY 2026, revenue has ranged from US$8.8b to US$9.7b while basic EPS moved from US$0.95 in Q1 to US$0.88 in Q2 and US$0.66 in Q3, alongside same store sales trends that went from a 0.7% decline in Q1 to...
NYSE:TTI
NYSE:TTIEnergy Services

TETRA Technologies (TTI) Is Down 24.3% After Record 2025 Sales But Q4 Loss - Has The Bull Case Changed?

TETRA Technologies, Inc. reported its fourth-quarter and full-year 2025 results, with quarterly sales rising to US$146.68 million but swinging from prior-year net income of US$102.72 million to a net loss of US$16.5 million, while full-year revenue increased to US$630.93 million and net income fell to US$3.01 million. Despite the sharp drop in reported earnings, management highlighted a record year in 2025 driven by offshore completion fluids, stronger adjusted profitability measures, and...
NYSE:MUR
NYSE:MUROil and Gas

A Look At Murphy Oil (MUR) Valuation After Ivory Coast Exploration Setback And Ongoing Offshore Plans

Why Murphy Oil’s Ivory Coast update matters for investors Murphy Oil (MUR) told investors its Caracal-1X exploration well offshore Ivory Coast will be plugged and abandoned as a dry hole, and the company and PETROCI will continue with the Bubale-1X prospect. See our latest analysis for Murphy Oil. Murphy Oil’s recent Ivory Coast update sits against a backdrop of strong momentum, with a 7.33% year to date share price return at a US$34.87 share price and a 50.05% one year total shareholder...
NYSE:ORCL
NYSE:ORCLSoftware

Assessing Oracle (ORCL) Valuation As AI Lawsuits Funding Needs And Analyst Upgrades Collide

Oracle (ORCL) is back in the spotlight as multiple securities fraud class action lawsuits, heavy AI infrastructure spending, and fresh analyst upgrades collide to raise new questions about risk, funding needs, and long-term opportunity. See our latest analysis for Oracle. Those class action filings and funding headlines have come during a period of weaker momentum, with a 30 day share price return of 9.46% and a 90 day share price return of 28.27%. This contrasts with the 3 year total...
NYSE:UVE
NYSE:UVEInsurance

Assessing Universal Insurance (UVE) Valuation After Strong Earnings Jump And Completed Share Buybacks

Universal Insurance Holdings (UVE) released fourth quarter and full year 2025 results, reporting higher revenue and net income than a year earlier, along with an update on its recently completed share repurchase activity. See our latest analysis for Universal Insurance Holdings. The latest results and completed buyback have come alongside strong share price momentum, with a 30 day share price return of 18.19% and a 1 year total shareholder return of 71.31%. This suggests investors have been...
NYSE:LLY
NYSE:LLYPharmaceuticals

Does Lilly’s Broad Pipeline Wins in Obesity and Immunology Reshape the Bull Case for LLY?

In late February 2026, Eli Lilly reported a series of product updates, including positive EMA guidance for Olumiant in adolescents with severe alopecia areata, strong Phase 3 data for oral GLP-1 candidate orforglipron versus oral semaglutide, label expansion for Zepbound’s monthly KwikPen, and durable multi-year results for Omvoh in inflammatory bowel disease. These developments highlight how Lilly is broadening its cardiometabolic and immunology franchises beyond injectable GLP-1s,...